ArticleFrontiers in oncology2025
A retroperitoneal urinoma secondary to metastatic urothelial carcinoma mimicking psoas muscle malignancy: Case Report and literature review.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aims to improve the understanding of imaging features of urinoma associated with urothelial carcinoma metastasis, enhance preoperative diagnostic accuracy, and reduce misdiagnosis rates. Methods: A 71-year-old male was admitted for evaluation following the incidental imaging detection of a left ureteral mass during an outpatient visit over the preceding 10 days. The patient was asymptomatic. Physical examination revealed a blood pressure of 195/88 mmHg, with no tenderness in either renal region. Laboratory investigations showed normal urinalysis and urinary cytology, with no tumor cells observed in urine smears. Contrast-enhanced CT urography (CTU) was subsequently performed. Results: Contrast-enhanced CT revealed a large cystic-solid mass in the left retroperitoneal and psoas muscle region, with poorly defined margins relative to the left kidney. The left ureter traversed the lesion and exhibited enhancement within the solid components, raising suspicion for a low-grade malignant tumor originating from the psoas muscle and involving the left kidney and ureter. Surgical pathology confirmed an invasive high-grade urothelial carcinoma of the left ureter, with infiltration into retroperitoneal cysts, the adjacent kidney, and the psoas muscle. Six months postoperatively, the tumor recurred and progressed rapidly, with evidence of widespread metastatic spread. Conclusion: CTU plays a crucial role in diagnosing urothelial tumors, though its accuracy may be limited in patients with kidney dysfunction. The characteristic course of the ureter traversing a mass, along with hyper enhancing solid components at the obstructed distal ureter and adjacent tissues, can assist in accurate diagnosis and help reduce the risk of misdiagnosis. However, surgery for locally invasive tumors risks spreading cancer cells and worsening outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.